心脏外科手术中组织因子通路抑制剂水平升高引起的血栓生成的术后减少:一项前性观察性研究
Akiko Kitajo1, Nobuyo Umehara1, Aya Takemoto1
1Department of Anesthesiology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Journal of anesthesia
|January 13, 2026
概括
心脏手术后增加的组织因子通路抑制剂 (TFPI) 降低了血栓生成 (TG). 这种TFPI增加会损害全血凝固,影响患者的康复.
科学领域:
- 心血管科学 心血管科学
- 血液学 血液学 血液学
- 凝血生理学 凝血生理学
背景情况:
- 组织因子通路抑制剂 (TFPI) 是一种关键的内在抗凝剂.
- 氨酸的使用会提高血TFPI水平.
- 在肝素逆转后的几个小时内,TFPI水平仍然升高,可能会影响手术后的凝血.
研究的目的:
- 研究TFPI在抑制血栓生成 (TG) 的作用.
- 检查TFPI对接受心肺旁路 (CPB) 心脏手术的患者的凝血的影响.
主要方法:
- 从心脏手术患者手术前,手术后和手术后1天收集血液样本.
- 测量了血TFPI度,TG峰值和全血凝固时间.
- 使用介电血凝量计和拉塞尔的毒蛇毒系统.
主要成果:
- 与手术前相比,手术后的血TFPI度明显高于手术前.
- 手术后的高峰TG值显著下降.
- 增加的TFPI与凝血时间正相关,与峰值TG负相关;抗TFPI抗体逆转了TG减少.
结论:
- 用CPB进行心脏手术后血TFPI增加会降低TG.
- 提升TFPI会通过抑制XA因子的活性来损害全血凝固.
- 这有助于在CPB程序后改变凝血动态.
相关概念视频
Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
Peripheral Artery Disease V: Postoperative Nursing Management
369
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
369
Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K


